Rilmenidine

This classification denotes an antihypertensive agent with the molecular formula C10H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P67IM25ID8, chemically known as 2-oxazolamine, n-(dicyclopropylmethyl)-4,5-dihydro- but generally known as rilmenidine, which bears US NIH Compound Identifier 68712. European Medicines Agency schedules Rilmenidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10316MIG. The term RILMENIDINE is an International Non-Proprietary Name. World Health Organization schedules rilmenidine in its Anatomical Therapeutic Chemical (ATC) Classification. RILMENIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rilmenidine under HS 29349990 and SITC 51579. As of Q4 2014, RILMENIDINE remains the US FDA Preferred Term for this commodity. Rilmenidine bears US NLM identifiers UMLS ID C0140591 and NCI Concept Code C75240. SMILES: C1CC1C(C2CC2)NC3=NCCO3.